Apolipoproteins Quantified Using Blood Volumetric Absorptive Microsampling and High-Throughput Mass Spectrometry for Risk Assessment in Ischemic Heart Disease-Reference-Cited by-同舟云学术

Apolipoproteins Quantified Using Blood Volumetric Absorptive Microsampling and High-Throughput Mass Spectrometry for Risk Assessment in Ischemic Heart Disease

Published:2024-03-19 Issue:12 Volume:149 Page:970-972
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Marano Paul¹^ORCID,Mouapi Kelly²,Kim Andy¹^ORCID,Mastali Mitra²,van den Broek Irene²,Manalo Danica²,Fu Qin²^ORCID,Cheng Susan¹^ORCID,Shufelt Chrisandra¹^ORCID,Spiegel Brennan³,Bairey Merz C. Noel¹^ORCID,Van Eyk Jennifer E.¹²^ORCID

Affiliation:

1. Barbra Streisand Women’s Heart Center, Smidt Heart Institute, Los Angeles, CA (P.M., A.K., S.C., C.S., C.N.B.M., J.E.V.E.).

2. Advanced Clinical Biosystems Research Institute, Cedars-Sinai Smidt Heart Institute, Los Angeles, CA (K.M., M.M., I.B., D.M., Q.F., J.E.V.E.).

3. Cedars-Sinai Center for Outcomes Research and Education, Cedars-Sinai Medical Center, Los Angeles, CA (B.S.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference5 articles.

1. Very-Low-Density Lipoprotein–Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III

2. Application of volumetric absorptive microsampling for robust, high-throughput mass spectrometric quantification of circulating protein biomarkers

3. Feasibility of Patient-Centric Remote Dried Blood Sampling: The Prediction, Risk, and Evaluation of Major Adverse Cardiac Events (PRE-MACE) Study

4. Quality Control and Outlier Detection of Targeted Mass Spectrometry Data from Multiplex Protein Panels

5. Biometric and Psychometric Remote Monitoring and Cardiovascular Risk Biomarkers in Ischemic Heart Disease